Dexcel Pharma

Business Overview

Dexcel Pharma is Israel’s largest private pharmaceutical company. Founded in 1968, we develop, manufacture and market value-added branded and generic pharmaceuticals. With a diverse product portfolio that spans more than 85 branded and generic products in over 175 dosage forms, our products are sold in the US, the UK and Germany, via subsidiaries and through a trusted network of partners in more than 30 countries worldwide.

Investor type
Company

Team

Dexcel Pharma
Ilan Oren
Co-CEO
Dexcel Pharma
Uri Oren
Co-CEO

Investment Portfolio

Startup

Operating Status

Offering Type

Business Model

Total Funding

AI Employees

Immunai
Active
Software
B2B
$80 M
10

Investment Rounds History

Startup

Date Announced

Funding Round

Amount Raised

Investors

Similar Investors

Ludis Capital
TYPE
Venture Capital
e.ventures
TYPE
Venture Capital
MIN CHEQUE
$0.5 M
Teuza
TYPE
Venture Capital
Samurai Incubate
TYPE
Incubator
MIN CHEQUE
$0.1 M
ZIG Ventures
TYPE
Venture Capital
Temasek
TYPE
Investment Firm
HBM Healthcare Investments
TYPE
Investment Firm
Citrosuco
TYPE
Company
TYPE
Angel
MEDX Venture Group
TYPE
Venture Capital
Hike Ventures
TYPE
Venture Capital
TLV Partners
TYPE
Venture Capital
3M New Ventures
TYPE
Corporate Venture Capital
Mosaic Ventures
TYPE
Venture Capital
Ground Up Ventures
TYPE
Venture Capital
MIN CHEQUE
$0.25 M
Foundation Capital
TYPE
Venture Capital
MIN CHEQUE
$6 M
Amdocs Ventures
TYPE
Corporate Venture Capital
Hasso Plattner Ventures
TYPE
Venture Capital
Oazis Accelerator
TYPE
Accelerator
Rho Capital Partners
TYPE
Private Equity
MIN CHEQUE
$5 M

Sign up for free

  • Save profiles to your list
  • View all funding rounds
  • Advanced sorting filter access
  • Search investment rounds
  • Search exit events

Sign up for Pro

  • Export lists (CSV, Excel) of startups and investors
  • View newly added AI startups
  • View investor emails
  • View investment funds and rounds sources
  • Advanced filters, sorting and search
  • Starting at just $15 per month